Announced
Completed
Financials
Tags
Friendly
Acquisition
Private
life sciences tools
Majority
Single Bidder
life sciences
United States
biotechnology company
Biotechnology
Cross Border
Completed
Synopsis
Abcam, a provider of life science research tools, completed the acquisition of BioVision, an innovator and distributor of life science research tools to biopharma, diagnostic and academic customers, for $340m. "We know the BioVision business well, having been a major distributor of their products since 2003. This acquisition represents a compelling opportunity to secure a proven portfolio of high-quality products, including a leading portfolio of biochemical and cell-based assay kits, that will allow us to better serve customer needs. BioVision has sustained strong growth over many years and, together with Abcam’s brand, reach and capabilities, we are confident we are well positioned to build on this success and reinforce Abcam’s ability to serve life scientists globally," Alan Hirzel, Abcam CEO.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.